Youm; Hyewon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Youm; Hyewon.The latest application filed is for "natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetes".

Company Profile

3.4.8

Youm; Hyewon - Berkeley Heights NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Natriuretic Peptide Receptor A Agonists Useful For The Treatment Of Cardiometabolic Diseases, Kidney Disease And Diabetes App 20220281886 - Bennett; Frank ; et al.	2022-09-08
Natriuretic Peptide Receptor A Agonists Useful For The Treatment Of Cardiometabolic Diseases, Kidney Disease And Diabetes App 20220273669 - Hong; Qingmei ; et al.	2022-09-01
PCSK9 antagonists bicyclo-compounds Grant 11,306,125 - Xiong , et al. April 19, 2	2022-04-19
Cyclic Polypeptides For Pcsk9 Inhibition App 20210284694 - Ricardo; Alonso ; et al.	2021-09-16
Pcsk9 Antagonists Bicyclo-compounds App 20210214395 - Xiong; Yusheng ; et al.	2021-07-15
Cyclic Polypeptides For Pcsk9 Inhibition App 20210163538 - Ricardo; Alonso ; et al.	2021-06-03
Substituted 1-methyl-1,2,3,4-tetrahydroisoquinoline molecules as PCSK9 allosteric binders Grant 11,008,313 - Imbriglio , et al. May 18, 2	2021-05-18
Substituted 1-methyl-1,2,3,4-tetrahydroisoquinoline Molecules As Pcsk9 Allosteric Binders App 20200369657 - Imbriglio; Jason Eugene ; et al.	2020-11-26
Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 Grant 9,877,957 - Imbriglio , et al. January 30, 2	2018-01-30
Isoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 Grant 9,828,369 - Imbriglio , et al. November 28, 2	2017-11-28
Tetrahydroisoquinoline Derivatives Useful As Inhibitors Of Diacylglyceride O-acyltransferase 2 App 20170273966 - Imbriglio; Jason ; et al.	2017-09-28
Isoquinoline Derivatives Useful As Inhibitors Of Diacylglyceride O-acyltransferase 2 App 20170275274 - Imbriglio; Jason ; et al.	2017-09-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.